BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29179646)

  • 1. Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer.
    Jeon MJ; Kim YN; Sung TY; Hong SJ; Cho YY; Kim TY; Shong YK; Kim WB; Kim SW; Chung JH; Kim TH; Kim WG
    Thyroid; 2018 Feb; 28(2):193-200. PubMed ID: 29179646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical Lymph Node Metastases After Thyroidectomy for Papillary Thyroid Carcinoma Usually Remain Stable for Years.
    Tomoda C; Sugino K; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Ito K
    Thyroid; 2016 Dec; 26(12):1706-1711. PubMed ID: 27616725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.
    Sapuppo G; Palermo F; Russo M; Tavarelli M; Masucci R; Squatrito S; Vigneri R; Pellegriti G
    J Endocrinol Invest; 2017 Dec; 40(12):1355-1363. PubMed ID: 28646475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk?
    Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Ito K
    Thyroid; 2020 Apr; 30(4):548-556. PubMed ID: 31910105
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymph node characteristics for predicting locoregional recurrence of papillary thyroid cancer in adolescents and young adults.
    Sun Y; Liu X; Ouyang W; Feng H; Wu J; Chen P; Wang J
    Oral Oncol; 2017 Mar; 66():22-27. PubMed ID: 28249644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
    Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
    J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrathyroidal Extension is an Important Predictor of Regional Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancer.
    Jain NK; Mostoufi-Moab S; Hawkes CP; Nelson ND; Surrey LF; Jones ZS; Adzick NS; Kazahaya K; Bauer AJ
    Thyroid; 2020 Jul; 30(7):1037-1043. PubMed ID: 31573414
    [No Abstract]   [Full Text] [Related]  

  • 9. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
    Jeon MJ; Yoon JH; Han JM; Yim JH; Hong SJ; Song DE; Ryu JS; Kim TY; Shong YK; Kim WB
    Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic risk stratification in papillary thyroid carcinoma measuring 1 to 4 cm.
    Lee YM; Cho JW; Hong SJ; Yoon JH
    J Surg Oncol; 2018 Sep; 118(4):636-643. PubMed ID: 30114339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Nomogram Based on the Characteristics of Metastatic Lymph Nodes to Predict Papillary Thyroid Carcinoma Recurrence.
    Jianyong L; Jinjing Z; Zhihui L; Tao W; Rixiang G; Jingqiang Z
    Thyroid; 2018 Mar; 28(3):301-310. PubMed ID: 29439612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.
    Randolph GW; Duh QY; Heller KS; LiVolsi VA; Mandel SJ; Steward DL; Tufano RP; Tuttle RM;
    Thyroid; 2012 Nov; 22(11):1144-52. PubMed ID: 23083442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.
    Leboulleux S; Rubino C; Baudin E; Caillou B; Hartl DM; Bidart JM; Travagli JP; Schlumberger M
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5723-9. PubMed ID: 16030160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.
    Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
    Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central lymph node metastasis in papillary thyroid microcarcinoma can be stratified according to the number, the size of metastatic foci, and the presence of desmoplasia.
    Cho SY; Lee TH; Ku YH; Kim HI; Lee GH; Kim MJ
    Surgery; 2015 Jan; 157(1):111-8. PubMed ID: 25444224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active Surveillance of Differentiated Thyroid Cancer Metastatic Cervical Lymph Nodes: A Retrospective Single-Center Cohort Study.
    Walter LB; Scheffel RS; Zanella AB; Farenzena M; Faccin CS; Graudenz MS; Dora JM; Maia AL
    Thyroid; 2023 Mar; 33(3):312-320. PubMed ID: 36680747
    [No Abstract]   [Full Text] [Related]  

  • 17. Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.
    Spinelli C; Tognetti F; Strambi S; Morganti R; Massimino M; Collini P
    World J Surg; 2018 Aug; 42(8):2444-2453. PubMed ID: 29383423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated Thyroid Cancer: The Role of ATA Nodal Risk Factors in N1b Patients.
    Taboni S; Paderno A; Giordano D; Albano D; Piana S; Zanetti E; Bertagna F; Grammatica A; Ghidini A; Cappelli C; Bozzola A; Baronchelli C; Nicolai P; Lombardi D
    Laryngoscope; 2021 Mar; 131(3):E1029-E1034. PubMed ID: 33319385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy.
    Park S; Kim WG; Song E; Oh HS; Kim M; Kwon H; Jeon MJ; Kim TY; Shong YK; Kim WB
    Thyroid; 2017 Apr; 27(4):524-530. PubMed ID: 27869547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
    Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
    Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.